Celldex Therapeutics Inc (CLDX)
36.28
+0.02
(+0.07%)
USD |
NASDAQ |
Apr 26, 16:00
36.28
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2013 | 3.31% |
| December 31, 2012 | 2.63% |
| September 30, 2012 | 3.44% |
| June 30, 2012 | 6.77% |
| March 31, 2012 | 3.66% |
| December 31, 2011 | -274.7% |
| September 30, 2011 | |
| June 30, 2011 | 0.56% |
| March 31, 2011 | 0.56% |
| December 31, 2010 | 81.97% |
| September 30, 2010 | 49.42% |
| June 30, 2010 | 41.31% |
| March 31, 2010 | 37.33% |
| December 31, 2009 | 42.36% |
| September 30, 2009 | 48.59% |
| June 30, 2009 | 49.01% |
| March 31, 2009 | 40.25% |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 |
| Date | Value |
|---|---|
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | -17.33% |
| December 31, 2005 | |
| September 30, 2005 | |
| June 30, 2005 | |
| March 31, 2005 | -315.3% |
| December 31, 2004 | |
| September 30, 2004 | |
| June 30, 2004 | |
| March 31, 2004 | |
| December 31, 2003 | |
| September 30, 2003 | |
| June 30, 2003 | |
| March 31, 2003 | |
| December 31, 2002 | |
| September 30, 2002 | 99.77% |
| June 30, 2002 | 97.36% |
| March 31, 2002 | 98.02% |
| December 31, 2001 | 98.92% |
| September 30, 2001 | 98.84% |
| June 30, 2001 | 99.01% |
| March 31, 2001 | |
| December 31, 2000 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ThermoGenesis Holdings Inc | -1.58% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 77.03% |
| Xtant Medical Holdings Inc | 60.97% |
| Asensus Surgical Inc | 21.47% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.69% |
| Return on Assets | -41.05% |
| Return on Invested Capital | -44.69% |
| Profit Margin (Quarterly) | -1.05K% |
| Operating Margin (Quarterly) | -850.3% |
| Return on Net Operating Assets | -399.9% |